Tag Archives: SuppreMol

March, 2015

  • 4 March

    Baxter Acquires Autoimmune Biotech SuppreMol

    Baxter International Inc. announced that it has agreed to acquire German biopharmaceutical company SuppreMol, expanding its portfolio of drugs for autoimmune diseases. Baxter is paying $225 million before working capital and other adjustments for the privately-held company, gaining SuppreMol’s early-stage development portfolio of novel biologic immunoregulatory therapeutics for treatment of …